Management of oral and gastrointestinal mucositis: ESMO clinical recommendations.
Peterson
D E
DE
Department of Oral Health and Diagnostic Sciences, School of Dental Medicine, Head and Neck/Oral Oncology Program, Neag Comprehensive Cancer Center, Farmington, USA.
Bensadoun
R-J
RJ
Roila
F
F
D000970:Antineoplastic Agents / Q000009:adverse effects; D019468:Disease Management; D005060:Europe / Q000453:epidemiology; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy*; D006287:Health Planning Guidelines; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology*; D052016:Mucositis / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy*; D012955:Societies, Medical / Q000592:standards*; D013280:Stomatitis / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy*
D000970:Antineoplastic Agents